The deal range was $150.00-$154.00. Morgan Stanley, Leerink, BofA and Cantor Fitzgerald acted as joint book running managers for the offering.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Mizuho upgrades Belite to Buy on ‘impressive’ Stargardt data
- Belite Bio upgraded to Outperform from Neutral at Mizuho
- Belite Bio TBA Spot Secondary; price range $150.00-$154.00
- Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
- Belite Bio Announces Public Offering of ADSs to Fund Expansion